Average Co-Inventor Count = 5.61
ph-index = 12
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Protagonist Therapeutics, Inc. (10 from 32 patents)
2. Smithkline Beecham Corporation (2 from 2,198 patents)
3. Glaxo Wellcome Inc. (2 from 281 patents)
4. Cytokinetics, Inc. (2 from 257 patents)
5. Life Technologies Corporation (1 from 1,820 patents)
6. Glaxosmithkline LLC (1 from 356 patents)
7. Affymax Technologies, N.v. (1 from 88 patents)
8. Carnegie Mellon University (1,123 patents)
19 patents:
1. 11840581 - α4β7 thioether peptide dimer antagonists
2. 11111272 - α4α7 peptide monomer and dimer antagonists
3. 10729676 - Opioid agonist peptides and uses thereof
4. 10626146 - α4β7 thioether peptide dimer antagonists
5. 10278957 - Opioid agonist peptides and uses thereof
6. 10059744 - α4β7 thioether peptide dimer antagonists
7. 9809623 - α4β7 peptide monomer and dimer antagonists
8. 9714270 - a4B7 integrin thioether peptide antagonists
9. 9518091 - A4B7 peptide monomer and dimer antagonists
10. 9273093 - α4β7 peptide dimer antagonists
11. 8993349 - Method for enhancing transport of semiconductor nanocrystals across biological membranes
12. 8227422 - Peptides and compounds that bind to a receptor
13. 7817840 - Predicting hepatotoxicity using cell based assays
14. 7235353 - Predicting hepatotoxicity using cell based assays
15. 7091311 - Peptides and compounds that bind to a receptor